Cleave raises $10M in series A extension

Cancer company Cleave Biosciences Inc. (Burlingame, Calif.) raised $10 million in an extension of a series A round from new investor New Enterprise Associates. The extension brings the total raised by Cleave in the round to $54 million; the company raised $44 million in October 2011. NEA's Robert Garland joined Cleave's board. ...